New cell implant aims to free type 1 diabetes patients from severe hypoglycemia
NCT ID NCT07581197
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests a new treatment called SR-02 for adults with type 1 diabetes who experience dangerously low blood sugar. The treatment involves implanting insulin-producing cells into the belly lining. Nine participants will receive the implant and must take lifelong immune-suppressing drugs to prevent rejection. The goal is to see if the implant is safe and can help the body produce its own insulin again.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETE MELLITUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Antioxidant-rich diets may fight inflammation in type 2 diabetes — a study investigates
- Can type 1 diabetes hold kids back from being fit and active? a study aims to find out.
- Fig leaf tea may shield kidneys from diabetes damage — a trial puts it to the test
- Could vinegar and fasting fix prediabetes cholesterol?
- Diabetes drug shows promise for repairing damaged nerves
- Foot flex could tame cholesterol and blood sugar